• Submit to Pharmaceutics Login Register
• MDPI
• Journals A-Z
• For Authors
• For Editors
• About
• Open Access Policy

• Pharmaceutics Home
• About this journal
• Indexing & Abstracting
• Instructions for Authors
• Publication Fees
• Special Issues
• Editorial Board

• Forthcoming Issue
• Current Issue
• Vol. 5 (2013)
• Vol. 4 (2012)
• Vol. 3 (2011)
• Vol. 2 (2010)
• Vol. 1 (2009)

Table of Contents

Pharmaceutics, Volume 1, Issue 1 (December 2009), Pages 1-19

• Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
• You may sign up for e-mail alerts to receive table of contents of newly released issues.
• PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Display options: Normal Show Abstracts Compact Export citation of selected articles as: Plain Text BibTeX BibTeX (without abstracts) Endnote Endnote (without abstracts) Tab-delimited PubMed XML DOAJ XML AGRIS XML
Select/unselect all Displaying article 1-2
	p. 1-2 Yvonne Perrie and Afzal R. Mohammed Editorial: Pharmaceutics: A New Open-Access Journal for All Those Interested in Designing Medicines Pharmaceutics 2009, 1(1), 1-2; doi:10.3390/pharmaceutics1010001 Received: 1 October 2009 / Published: 2 October 2009 Show/Hide Abstract | Download PDF Full-text (19 KB) Abstract: We know the many hurdles that face us when we look to deliver a drug, starting from the basic characteristics of the drug (its solubility, stability, absorption and biodistribution), to overcoming the physiological barriers faced in reaching the target site, and to maintaining the concentration within the therapeutic window. In addition we must also remember the patient needs in this – is it a child that needs a liquid dosage form? Is it someone having to take multiple doses in a day? Do we need a rapid onset of action in a convenient format? Will people find it convenient to take the drug in the format we are presenting to them – or are there alternative options? [...]
	p. 3-19 Adamo Fini, Cristina Cavallari and Francesca Ospitali Article: Effect of Ultrasound on the Compaction of Ibuprofen/Isomalt Systems Pharmaceutics 2009, 1(1), 3-19; doi:10.3390/pharmaceutics1010003 Received: 6 August 2009; in revised form: 3 October 2009 / Accepted: 6 October 2009 / Published: 9 October 2009 Show/Hide Abstract | Download PDF Full-text (1533 KB) Abstract: Six mixtures, containing 10, 20 and 30% w/w ibuprofen and isomalt, were compacted by a traditional or ultrasound-assisted machine and analysed by means of thermal (DSC and TGA) and micro-spectrometry (Raman and FT-IR) techniques. Ultrasound discharge causes melting of ibuprofen powder, transforming into a paste that could not assume the shape of a tablet; when in mixture with isomalt, thermal events, occurring during ultrasound compaction, change the appearance of the particles formed by milling the tablets obtained this way and SEM photos reveal a dramatic reduction of the particle size and changes due to a possible ibuprofen re-crystallization. Raman and FT-IR spectra of small portions of the surface and of the bulk, using characteristic peaks for identification, reveal that in ultrasound-compacted tablets ibuprofen partially disappears from the top face of the tablet.
Select/unselect all Displaying article 1-2
Export citation of selected articles as: Plain Text BibTeX BibTeX (without abstracts) Endnote Endnote (without abstracts) Tab-delimited PubMed XML DOAJ XML AGRIS XML